Skip to main content
Clinical Trials/NL-OMON32206
NL-OMON32206Not yet recruitingNot Applicable

Evaluation of the predictive value of Dynamic MRI in determining treatment response in perianal fistulizing Crohn*s disease before and after treatment with Infliximab - DCE-MRI in predicting treatment response perianal fistulizing CD.

Academisch Medisch Centrum0 sites33 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
33

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • proven Crohn*s disease by endoscopy and/or histopathology
  • draining perianal fistula

Exclusion Criteria

  • under 18 years of age
  • general contraindications to MRI (claustrophobia, pregnancy, renal insufficiency, pacemakers).

Investigators

Similar Trials